We’ll jump to be the leading enterprise specialized for raw pharmaceutical ingredients with a spirit of ‘challenge and creation’ in the world!
The research institute will devote itself into developing technologies with constant passion and a spirit of challenge for the 3 core fields of project development through 1) R&D of raw pharmaceutical ingredients, 2) developing CMO technologies and 3) joint researches for PolarisAIPharma Co., Ltd. to move forward to be a manufacturer with international competitiveness as a company for raw pharmaceutical ingredients based on development of technologies and R&D for health of humanity.
We’ll more strive for R&D to survive infinite competition which only companies based on technical skills and quality can survive, and concentrate the competence of research on the direction of developing general chiral technology
which selectively combines a specific optical active substance that is a high-valued precise chemistry product requiring high technology, organic metal complex technology, a synthesis technology using a reaction with hydrogen under existence of a catalyst and a high-degree complex technology such as compound synthesis etc. through the control on reaction under high temperature/high pressure in the long term.
Simultaneously, we’ll introduce excellent basic technologies through a joint research with overseas research institutes and partners at home and abroad to develop new technologies and do our best to expand advancement to markets of developed countries such as Europe, Japan and the U.S. etc. with an aim to be the leading company in the world competing and cooperating with companies in developed countries on the international stage by striving for commercialization of the exclusive and topnotch technology through identifying the latest trend of markets and related industries.
We’ve played a key role in development to be a manufacturer of raw pharmaceutical ingredients and intermediate products through perpetual efforts and challenges since its establishment.
With an aim of producing raw pharmaceutical ingredients with the best quality at home and abroad, we’ve entered markets of Japan and each country of the world as well as domestic market by developing and producing raw pharmaceutical ingredients complying with demands of each country in the world focusing on intensive investment on R&D over 10% of the sales every year and excellent research personnel since its establishment.
As a result of these efforts, we’ve succeeded in mass production of many products that are currently produced for the first time in the country and achieved development and mass production of some items for the 2nd or 3rd time in the world.
We’ve developed high-quality raw pharmaceutical ingredients promptly such as medicine for allergic asthma, diabetes, Parkinson’s disease and a contrast medium for MRI based on accumulated technologies and experiences in development and excellent facilities and also as a part of it, we’ve developed and produced intermediate products and raw materials for new medicine of pharmaceutical companies at home and abroad.
We strive for R&D to survive the environment of international competition that only companies based on technical skills and quality can survive, and we’ve developed precise chemistry synthesis technology, a chiral technology that selectively proceeds with synthesis and separation of optical active substances, organic metal complex technology, a synthesis technology using hydorgenization in addition to micronization and compound synthesis through a control on reaction under high temperature/high pressure, which are accumulated in the meantime and we’ll concentrate on the competence of research in the long term to secure high-degree complex technologies.
Simultaneously, we’ll introduce excellent technologies for raw pharmaceutical ingredients and manufacturing precise chemistry products through joint researches with overseas research institutes, universities and partners at home and abroad to develop new technologies and strive for commercialization of the topnotch technologies through identifying the latest trend of markets and related industries and do our best in enhancing the competence of developing technologies to expand advancement to markets of developed countries such as Europe, Japan and the U.S. with an aim to be the leading company in the world competing and cooperating with companies in developed countries on the international stage.
